varVAMP: degenerate primer design for tiled full genome sequencing and qPCR.

Publication date: May 31, 2025

Time- and cost-saving surveillance of viral pathogens is achieved by tiled sequencing in which a viral genome is amplified in overlapping PCR amplicons and qPCR. However, designing pan-specific primers for viral pathogens with high genomic variability represents a significant challenge. Here, we present a bioinformatics command-line tool, called varVAMP (variable virus amplicons), which addresses this issue. It relies on multiple sequence alignments of highly variable virus sequences and enables degenerate primer design for qPCR or tiled amplicon whole genome sequencing. We demonstrate the utility of varVAMP by designing and evaluating novel pan-specific primer schemes suitable for sequencing the genomes of SARS-CoV-2, Hepatitis E virus, rat Hepatitis E virus, Hepatitis A virus, Borna-disease-virus-1, and Poliovirus using clinical samples. Importantly, we also designed primers on the same input data using the software packages PrimalScheme and Olivar and showed that varVAMP minimizes primer mismatches most efficiently. Finally, we established highly sensitive and specific Poliovirus qPCR assays that could potentially simplify current Poliovirus surveillance. varVAMP is open-source and available through PyPI, UseGalaxy, Bioconda, and https://github. com/jonas-fuchs/varVAMP .

Open Access PDF

Concepts Keywords
Degenerate Degenerate
Genomes Design
Hepatitis Genome
Pcr Hepatitis
Surveillance Pathogens
Poliovirus
Primer
Qpcr
Sequencing
Specific
Surveillance
Tiled
Varvamp
Viral
Virus

Semantics

Type Source Name
drug DRUGBANK Coenzyme M
disease MESH Hepatitis
disease IDO cell
disease MESH Poliomyelitis
disease MESH Influenza
disease IDO pathogen
drug DRUGBANK Gold
disease IDO algorithm
pathway REACTOME Digestion
disease IDO blood
drug DRUGBANK Diethylpropion
drug DRUGBANK Trestolone
disease IDO assay
drug DRUGBANK Flunarizine
drug DRUGBANK Proline
drug DRUGBANK Piroxicam
drug DRUGBANK Ribavirin
disease IDO quality
disease MESH Infection
disease IDO site
drug DRUGBANK Guanine
disease MESH mutation frequency
drug DRUGBANK Pentaerythritol tetranitrate
disease IDO production
drug DRUGBANK Cefaclor
drug DRUGBANK Streptomycin
drug DRUGBANK L-Glutamine
disease MESH carcinoma
drug DRUGBANK Methylergometrine
disease IDO reagent
disease IDO nucleic acid
drug DRUGBANK Tretamine
drug DRUGBANK Ranitidine
drug DRUGBANK Trimebutine

Original Article

(Visited 1 times, 1 visits today)